- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.02. | BridgeBio gets EU nod for ATTR cardiomyopathy drug | ||
| 12.02. | Storybook can help kids understand rare kidney disease | ||
| 12.02. | Trump 'fired Inspector General over critical USAID report' | ||
| 11.02. | Novartis builds in cardiovascular with $3.1bn Anthos buy | ||
| 11.02. | Ten years on, Roche jettisons InterMune and Esbriet in US | ||
| 11.02. | Merck confirms its interest in buying SpringWorks | ||
| 11.02. | Ten years on, Roche jettisons InterMune and Esbriet | ||
| 11.02. | Boehringer drug scores in another pulmonary fibrosis trial | ||
| 11.02. | Judge orders block on Trump's NIH funding cuts | ||
| 10.02. | Pliant slumps on decision to pause lung disease drug trial | ||
| 10.02. | Industry steps up as EU debates an action plan for AI | ||
| 10.02. | FDA clears new antibiotic for superbug infections | ||
| 10.02. | Share in cystic fibrosis firm Sionna rise sharply after IPO | ||
| 10.02. | NIH indirect funding cuts appals medical research groups | ||
| 07.02. | USAID could see workforce cut to 600 as stop-work looms | ||
| 07.02. | Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn | ||
| 07.02. | MSD starts pivotal trial of ROR1 drug in first-line lymphoma | ||
| 07.02. | FDA starts review of first bronchiectasis drug candidate | ||
| 07.02. | Trump 'planning mass job cuts at US health agencies' | ||
| 06.02. | BMS extends its cost-cutting drive by another $2bn | ||
| 06.02. | Pressure relieved on AZ as details of Chinese probe emerge | ||
| 06.02. | Newel's VR therapy for chronic pain nears EU market | ||
| 06.02. | Pharma group slams Hims & Hers over Super Bowl GLP-1 ad | ||
| 06.02. | Novo charts course ahead for CagriSema after lacklustre data | ||
| 05.02. | FDA expands label for Roche's eye disease implant Susvimo |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
